NORTHERN TRUST CORP - MONOPAR THERAPEUTICS INC ownership

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 11 filers reported holding MONOPAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$51,505
-39.8%
37,051
+2.7%
0.00%
Q4 2022$85,512
+55.5%
36,081
-0.8%
0.00%
Q3 2022$55,000
-32.1%
36,374
+3.3%
0.00%
Q2 2022$81,000
-10.0%
35,203
-0.0%
0.00%
Q1 2022$90,000
-21.7%
35,207
-2.0%
0.00%
Q4 2021$115,000
-35.0%
35,920
-1.2%
0.00%
Q3 2021$177,000
-16.9%
36,339
+0.6%
0.00%
Q2 2021$213,000
-4.5%
36,106
+0.3%
0.00%
Q1 2021$223,000
-38.1%
36,001
-38.8%
0.00%
Q4 2020$360,000
+3.7%
58,793
-9.2%
0.00%
Q3 2020$347,000
-6.7%
64,748
+30.1%
0.00%
Q2 2020$372,00049,7530.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
American Portfolios Advisors 700$1,6100.00%
ROYAL BANK OF CANADA 4,116$9,0000.00%
VANGUARD GROUP INC 99,879$230,0000.00%
UBS Group AG 19,561$45,0000.00%
IFP Advisors, Inc 500$13,0000.00%
FMR LLC 10$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 35,203$81,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 39,171$85,0000.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders